These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 9617981)

  • 61. High plasma serotonin levels in primary pulmonary hypertension. Effect of long-term epoprostenol (prostacyclin) therapy.
    Kéreveur A; Callebert J; Humbert M; Hervé P; Simonneau G; Launay JM; Drouet L
    Arterioscler Thromb Vasc Biol; 2000 Oct; 20(10):2233-9. PubMed ID: 11031209
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Plasma and platelet amino acid concentrations in patients affected by major depression and under fluvoxamine treatment.
    Mauri MC; Ferrara A; Boscati L; Bravin S; Zamberlan F; Alecci M; Invernizzi G
    Neuropsychobiology; 1998; 37(3):124-9. PubMed ID: 9597668
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Differential abnormalities in plasma 5-HIAA and platelet serotonin concentrations in violent suicide attempters: relationships with impulsivity and depression.
    Spreux-Varoquaux O; Alvarez JC; Berlin I; Batista G; Despierre PG; Gilton A; Cremniter D
    Life Sci; 2001 Jun; 69(6):647-57. PubMed ID: 11476186
    [TBL] [Abstract][Full Text] [Related]  

  • 64. A double-blind study of zimelidine, a serotonin uptake inhibitor, and desipramine, a noradrenaline uptake inhibitor, in endogenous depression. II. Biochemical findings.
    Aberg-Wistedt A; Ross SB; Jostell KG; Sjöquist B
    Acta Psychiatr Scand; 1982 Jul; 66(1):66-82. PubMed ID: 6181652
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Tryptophan to competing amino acids ratio in depressive disorder: relation to efficacy of antidepressive treatments.
    Møller SE
    Acta Psychiatr Scand Suppl; 1985; 325():3-31. PubMed ID: 2418637
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Does platelet serotonin receptor supersensitivity accompany endogenous depression?
    Brusov OS; Beliaev BS; Katasonov AB; Zlobina GP; Factor MI; Lideman RR
    Biol Psychiatry; 1989 Feb; 25(4):375-81. PubMed ID: 2930807
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Serotonin reuptake inhibition vs. norepinephrine reuptake inhibition: a double-blind differential-therapeutic study with fluvoxamine and oxaprotiline in endogenous and neurotic depressives.
    Emrich HM; Berger M; Riemann D; von Zerssen D
    Pharmacopsychiatry; 1987 Mar; 20(2):60-3. PubMed ID: 3108909
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Altered platelet serotonin uptake kinetics in schizophrenia and depression.
    Kaplan RD; Mann JJ
    Life Sci; 1982 Aug; 31(6):583-8. PubMed ID: 7132568
    [TBL] [Abstract][Full Text] [Related]  

  • 69. The influence of daylight exposure on platelet 5-HT levels in patients with major depression and schizophrenia.
    Ljubicić D; Stipcević T; Pivac N; Jakovljević M; Mück-Seler D
    J Photochem Photobiol B; 2007 Dec; 89(2-3):63-9. PubMed ID: 17937992
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Platelet serotonin content and free and total plasma tryptophan in healthy volunteers during 24 hours.
    Eynard N; Flachaire E; Lestra C; Broyer M; Zaidan R; Claustrat B; Quincy C
    Clin Chem; 1993 Nov; 39(11 Pt 1):2337-40. PubMed ID: 8222232
    [TBL] [Abstract][Full Text] [Related]  

  • 71. 5-HT uptake inhibitors and tricyclic antidepressants: relation between tryptophan availability and clinical response in depressed patients.
    Møller SE
    Eur Neuropsychopharmacol; 1990 Nov; 1(1):41-4. PubMed ID: 2136212
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Predictive value of amino acids in the treatment of major depression with fluvoxamine.
    Mauri MC; Boscati L; Volonteri LS; Scalvini ME; Steinhilber CP; Laini V; Zamberlan F
    Neuropsychobiology; 2001; 44(3):134-8. PubMed ID: 11586053
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Is there a relationship between morphological and functional platelet changes and depressive disorder?
    Tagliarini C; Carbone MG; Pagni G; Marazziti D; Pomara N
    CNS Spectr; 2022 Apr; 27(2):157-190. PubMed ID: 33092669
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Biological parameters in major depression: effects of paroxetine, viloxazine, moclobemide, and electroconvulsive therapy. Relation to early clinical outcome.
    Lestra C; d'Amato T; Ghaemmaghami C; Perret-Liaudet A; Broyer M; Renaud B; Dalery J; Chamba G
    Biol Psychiatry; 1998 Aug; 44(4):274-80. PubMed ID: 9715359
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Treatment of bronchial asthma with tianeptine.
    Lechin F; van der Dijs B; Lechin AE
    Methods Find Exp Clin Pharmacol; 2004 Nov; 26(9):697-701. PubMed ID: 15632955
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Diurnal and seasonal variations in human platelet serotonin in man.
    Wirz-Justice A; Lichtsteiner M; Feer H
    J Neural Transm; 1977; 41(1):7-15. PubMed ID: 562392
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Seasonal incidence of an altered diurnal rhythm of platelet serotonin in unipolar depression.
    Wirz-Justice A; Pühringer W
    J Neural Transm; 1978; 42(1):45-53. PubMed ID: 565390
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Effects of fluvoxamine on whole-blood serotonin and platelet number.
    Hoeksema T; Goekoop JG; Van Kempen GM
    J Clin Psychopharmacol; 1993 Feb; 13(1):75-6. PubMed ID: 8486822
    [No Abstract]   [Full Text] [Related]  

  • 79. Decreased plasma neuroactive amino acids and increased nitric oxide levels in melancholic major depressive disorder.
    Lu YR; Fu XY; Shi LG; Jiang Y; Wu JL; Weng XJ; Wang ZP; Wu XY; Lin Z; Liu WB; Li HC; Luo JH; Bao AM
    BMC Psychiatry; 2014 Apr; 14():123. PubMed ID: 24767108
    [TBL] [Abstract][Full Text] [Related]  

  • 80. The content and uptake of 5-HT by blood platelets in depressive patients.
    Oxenkrug GF
    J Neural Transm; 1979; 45(4):285-9. PubMed ID: 490151
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.